Virtus ETF Advisers’s Sorrento Therapeutics, Inc. SRNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-125,062
| Closed | -$111K | – | 506 |
|
|
2022
Q4 | $111K | Buy |
125,062
+50,975
| +69% | +$45.2K | 0.06% | 435 |
|
|
2022
Q3 | $116K | Buy |
74,087
+540
| +0.7% | +$845 | 0.05% | 405 |
|
|
2022
Q2 | $148K | Buy |
73,547
+48,120
| +189% | +$96.8K | 0.05% | 321 |
|
|
2022
Q1 | $59K | Sell |
25,427
-1,501
| -6% | -$3.48K | 0.03% | 360 |
|
|
2021
Q4 | $125K | Buy |
26,928
+4,463
| +20% | +$20.7K | 0.05% | 368 |
|
|
2021
Q3 | $171K | Sell |
22,465
-1,181
| -5% | -$8.99K | 0.08% | 308 |
|
|
2021
Q2 | $229K | Sell |
23,646
-16,454
| -41% | -$159K | 0.09% | 246 |
|
|
2021
Q1 | $332K | Buy |
40,100
+713
| +2% | +$5.9K | 0.14% | 220 |
|
|
2020
Q4 | $269K | Sell |
39,387
-27,464
| -41% | -$188K | 0.11% | 283 |
|
|
2020
Q3 | $745K | Sell |
66,851
-9,133
| -12% | -$102K | 0.39% | 99 |
|
|
2020
Q2 | $477K | Sell |
75,984
-12,358
| -14% | -$77.6K | 0.23% | 155 |
|
|
2020
Q1 | $163K | Sell |
88,342
-12,874
| -13% | -$23.8K | 0.07% | 284 |
|
|
2019
Q4 | $342K | Buy |
101,216
+21,002
| +26% | +$71K | 0.06% | 285 |
|
|
2019
Q3 | $172K | Sell |
80,214
-4,468
| -5% | -$9.58K | 0.03% | 270 |
|
|
2019
Q2 | $226K | Sell |
84,682
-23,079
| -21% | -$61.6K | 0.05% | 281 |
|
|
2019
Q1 | $512K | Sell |
107,761
-16,062
| -13% | -$76.3K | 1.09% | 28 |
|
|
2018
Q4 | $297K | Buy |
123,823
+61,132
| +98% | +$147K | 0.05% | 114 |
|
|
2018
Q3 | $276K | Sell |
62,691
-46,025
| -42% | -$203K | 0.03% | 188 |
|
|
2018
Q2 | $783K | Buy |
+108,716
| New | +$783K | 0.69% | 42 |
|
|
2016
Q4 | – | Sell |
-40,438
| Closed | -$313K | – | 195 |
|
|
2016
Q3 | $313K | Hold |
40,438
| – | – | 0.15% | 96 |
|
|
2016
Q2 | $226K | Buy |
40,438
+4,308
| +12% | +$24.1K | 0.17% | 119 |
|
|
2016
Q1 | $194K | Buy |
+36,130
| New | +$194K | 0.27% | 90 |
|